Targeted gonadotrophin stimulation using the PIVET algorithm markedly reduces the risk of OHSS

Reproductive BioMedicine Online

Volumn 24, Issue 3, 2012, Pages 281-292

  Yovich, John ^a   Stanger, James ^a   Hinchliffe, Peter ^a  

^a PIVET Medical Centre   (Australia)

Author keywords

anti M llerian hormone (AMH); antral follicle count (AFC); BMI; IVF; ovarian hyperstimulation syndrome (OHSS); rFSH dose

Indexed keywords

CABERGOLINE; CHORIONIC GONADOTROPIN; ESTRADIOL; LEUPRORELIN; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; ALGORITHM; ARTICLE; FEMALE; HORMONAL REGULATION; HUMAN; INCIDENCE; LUTEAL PHASE; OOCYTE RETRIEVAL; OVARY HYPERSTIMULATION; PATIENT MONITORING; PATIENT REFERRAL; PIVET ALGORITHM; PREGNANCY RATE;

ADULT; AGE FACTORS; ALGORITHMS; ANTI-MULLERIAN HORMONE; BODY MASS INDEX; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INCIDENCE; OVARIAN FOLLICLE; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; RETROSPECTIVE STUDIES; SMOKING;

EID: 84857911081     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2011.11.014     Document Type: Article

References (32)

1. M. Al-Azemi, S.R. Killick, S. Duffy, C. Pye, B. Refaat, N. Hill, and W. Ledger Multi-marker assessment of ovarian reserve predicts oocyte yield after ovulation induction Hum. Reprod. 26 2011 414 422
2. C. Álvarez, I. Alonso-Muriel, G. García, J. Crespo, J. Bellver, C. Simon, and A. Pellicer Implantation is apparently unaffected by the dopamine agonist cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment Hum. Reprod. 22 2007 3210 3214 (Pubitemid 351696781)
3. A. Andersen, A. Balen, P. Platteau, P. Devroey, L. Helmgaard, and J.C. Arce Predicting the FSH threshold dose in women with WHO Group II anovulatory infertility failing to ovulate or conceive on clomiphene citrate Hum. Reprod. 23 2008 1424 1430 (Pubitemid 351770572)
4. D. Barad, and N. Gleicher Increased oocyte production after treatment with dehydroepiandrosterone Fertil. Steril. 84 2005 756 758
5. D. Barad, and N. Gleicher Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF Hum. Reprod. 21 2006 2845 2849 (Pubitemid 44566996)
6. S.L. Broer, M. Dollemann, B.C. Opmeer, B.C. Fauser, B.W. Mol, and F.J.M. Broekmans AMH and AFC as predictors of excessive response in a controlled ovarian hyperstimulation: a meta-analysis Hum. Reprod. Update 17 2011 46 54
7. J. Collins Mild stimulation for in vitro fertilization: making progress downward Hum. Reprod. Update 15 2009 1 3
8. C. De Koning, J. Schoemaker, and C. Lambalk Estimation of the follicle-stimulating hormone (FSH) threshold for initiating the final stages of follicular development in women with elevated FSH levels in the early follicular phase Fertil. Steril. 82 2004 650 653 (Pubitemid 39243187)
9. J. Fisch, L. Keskinteppe, and G. Sher Gonadotrophin-releasing hormone agonist/antagonist conversion with estrogen priming in low responders with prior in vitro fertilization failure Fertil. Steril. 89 2008 342 347 (Pubitemid 351215402)
10. V. Genro, M. Grynberg, J. Scheffer, I. Roux, R. Frydman, and R. Fanchin Serum anti-Müllerian hormone levels are negatively related to Follicular Output RaTe (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation Hum. Reprod. 26 2011 671 677
11. N. La Cour Freiesleben, T. Gerds, J. Forman, J.D. Silver, A. Nyboe-Andersen, and B. Popovic-Todorovic Risk charts to identify low and excessive responders among first-cycle IVF/ICSI standard patients Reprod. Biomed. Online 22 2011 50 58
12. S. Nelson, R. Yates, and R. Fleming Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles - implications for individualization of therapy Hum. Reprod. 22 2007 2414 2421 (Pubitemid 47289055)
13. S.M. Nelson, R.W. Yates, H. Lyall, M. Jamieson, I. Traynor, M. Gaudoin, P. Mitchell, P. Ambrose, and R. Fleming Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception Hum. Reprod. 24 2009 867 875
14. E.U. Ng, W. Yeung, E.Y.L. Lau, E.H.Y. Ng, W.S.B. Yeung, E.Y.L. Lau, W.W.K. So, and P.C. Ho High serum oestradiol concentrations in fresh IVF cycles do not impair implantation and pregnancy rates in subsequent frozen-thawed embryo transfer cycles Hum. Reprod. 15 2000 250 255 (Pubitemid 30076702)
15. F. Oliviennes, C.M. Howles, A. Borini, M. Germond, G. Trew, M. Wikland, F. Zegers-Hochschild, H. Saunders, and V. Alam Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study Reprod. Biomed. Online 18 2009 195 204
16. O. Oktem, and B. Uramn Understanding follicle growth in vivo Hum. Reprod. 25 2010 2944 2954
17. T. Papageorgiou, J. Guibert, F. Goffinet, C. Patrat, Y. Fulla, Y. Janssens, and J.R. Zorn Percentile curves of serum estradiol levels during controlled ovarian stimulation in 905 cycles stimulated with recombinant FSH show that high estradiol is not detrimental to IVF outcome Hum. Reprod. 17 2002 2846 2850 (Pubitemid 35350900)
18. M.J. Pelinck, H.M. Knol, N.E.A. Vogel, E.G.J.M. Arts, A.H.M. Simons, M.J. Heineman, and A. Hoek Cumulative pregnancy rates after sequential treatment with modified natural cycle IVF followed by IVF with controlled ovarian stimulation Hum. Reprod. 23 2008 1808 1814 (Pubitemid 352020004)
19. J.E. Pena, P.L. Chang, L.K. Chan, K. Zeitoun, M.H. Thornton II, and M.V. Sauer Supraphysiological estradiol levels do not affect oocyte and embryo quality in oocyte donation cycles Hum. Reprod. 17 2002 83 87 (Pubitemid 34130265)
20. B. Popovic-Todorovic, A. Loft, A. Lindhard, S. Bangsboll, A.M. Andersson, and A. Nyboe Andersen A prospective study of predictive factors of ovarian response in standard IVF/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram Hum. Reprod. 18 2003 781 787 (Pubitemid 36426957)
21. A. Raziel, S. Friedler, M. Schachter, D. Strassburger, E. Mordechai, and R. Ron-El Increased early pregnancy loss in IVF patients with severe ovarian hyperstimulation syndrome Hum. Reprod. 17 2002 107 110 (Pubitemid 34130270)
22. R.S. Robinson, K.J. Woad, A.J. Hammond, M. Laird, M.G. Hunter, and G.E. Mann Angiogenesis and vascular function in the ovary Reproduction 38 2009 869 881
23. C. Rubio, A. Mercader, P. Alamá, C. Lizan, L. Rodrigo, E. Labarta, M. Melo, A. Pellicer, and J. Remohi Prospective cohort study in high responder oocyte donors using two hormonal stimulation protocols: impact on embryo aneuploidy and development Hum. Reprod. 25 2010 2290 2297
24. M.D. Sterrenburg, S.M. Veltman-Verhulst, M.J.C. Eijkemans, E.G. Hughes, N.S. Maklon, F.J. Broekmans, and B.C.J.M. Fauser Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis Hum. Reprod. Updates 17 2011 184 196
25. E.A. Sullivan, Y.A. Wang, and G. Chambers Assisted reproductive technology in Australia and New Zealand 2008. Cat. No. PER 49 2010 AIHW Canberra
26. T. Matsuura, Y. Takehara, H. Kaijima, S. Teramoto, and O. kato Natural IVF cycles may be desirable for women with repeated failures by stimulated IVF cycles J. Assist. Reprod. Genet. 25 2008 163 167
27. M.F.G. Verberg, M.J.C. Eijkemans, N.S. Macklon, E.M.E.W. Heijnen, E.B. Baart, F.P. Hohmann, B.C.J.M. Fauser, and F.J. Broekmans The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis Hum. Reprod. Update 15 2009 5 12
28. M.F.G. Verberg, N.S. Macklon, G. Nargund, R. Frydman, P. Devroey, F.J. Broekmans, and B.C.J.M. Fauser Mild ovarian stimulation for IVF Hum. Reprod. Update 15 2009 13 29
29. A.L. Waylen, M. Metwally, G.L. Jones, A.J. Wilkinson, and W.L. Ledger Effects of cigarette smoking upon clinical outcomes of assisted reproduction: a meta-analysis Hum. Reprod. Update 15 2009 31 44
30. J. Yovich, and J. Stanger Growth hormone supplementation improves implantation and pregnancy productivity rates for poor-prognosis patients undertaking IVF Reprod. Biomed. Online 21 2010 37 49
31. J. Zhang, L. Chang, Y. Sone, and S. Silber Minimal ovarian stimulation (mini-IVF) for IVF utilizing vitrification and cryopreserved embryo transfer Reprod. Biomed. Online 21 2010 485 495
32. S. Ziebe, S. Bangsbøll, K.L.T. Schmidt, A. Loft, A. Lindhard, and A. Nyboe Andersen Embryo quality in natural versus stimulated IVF cycles Hum. Reprod. 19 2004 1457 1460 (Pubitemid 38807723)